Delta-Fly Pharma (4598) · RiskRestated
Impact of global instability and geopolitical risk on clinical trials
First written in FY2024. 1 of 2 entries say "Restated". Latest entry: FY2026.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Risk of research and development and manufacturing shutdowns due to infectious diseases, natural disasters, wars, and other eventsA theme 5 companies write about · 5 as a headwind · 0 as a tailwind
3 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2026RestatedAnnual report
「If prolonged global instability or geopolitical risks affect ongoing or planned clinical trials in Japan and the United States, we will consider and implement trials in regions with a high likelihood of execution, taking into account the status of trial sites in both countries.」
世界的情勢不安・地政学的リスクが臨床試験に影響する可能性を引き続き記載している。 - FY2024First statedAnnual report
「If prolonged global instability or geopolitical risks affect ongoing or planned clinical trials in Japan and the United States, we will consider and implement trials in regions with a high likelihood of execution, taking into account the status of trial sites in both countries.」
世界的情勢不安・地政学的リスクが日米の進行中及び計画中の臨床試験に影響を及ぼす可能性を、臨床開発に関する個別リスクとして初めて記載している。